PAVE ITS-MCI
DEAD

Serial Number

79129105

Owner

Genloci Biotechnologies Inc.

Filing Date

Dec 21, 2012

Add to watchlist:

No watchlists yet
View on USPTO

PAVE ITS-MCI Trademark

Serial Number: 79129105

PAVE ITS-MCI is a trademark filed by Genloci Biotechnologies Inc. on December 21, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genloci Biotechnologies Inc. (7 trademarks)

Floor 13-A, Bldg. 1

Entity Type: 03

Trademark Details

Filing Date

December 21, 2012

Registration Date

Not Registered

Goods & Services

Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietary and nutritional supplements for medical use

Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes

Technical research in field of medicines and pharmaceuticals; technical project studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 20, 2023 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 20, 2023 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2015 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2014 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 12, 2014 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2014 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 15, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 15, 2014 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 12, 2013 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 12, 2013 ABN2
REFUSAL PROCESSED BY IB
Jun 5, 2013 RFNT
APPLICATION FILING RECEIPT MAILED
May 18, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2013 RFCS
REFUSAL PROCESSED BY MPU
May 16, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 16, 2013 RFCR
NON-FINAL ACTION WRITTEN
May 15, 2013 CNRT
ASSIGNED TO EXAMINER
May 14, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 13, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2013 REPR